Literature DB >> 1882739

Reduced hypothalamic blood flow after radiation treatment of nasopharyngeal cancer: SPECT studies in 34 patients.

P U Chieng1, T S Huang, C C Chang, P N Chong, R D Tien, C T Su.   

Abstract

To determine the effect of cranial irradiation on hypothalamic blood flow, we performed 44 regional cerebral blood flow studies with 99mTc hexamethyl propyleneamine oxime (HMPAO) single-photon emission CT (SPECT) on four normal volunteers and 34 patients with pathologically proved nasopharyngeal cancer. Twenty-three men and 15 women, 30-65 years old, were divided into four study groups: group 1 served as a control and consisted of four normal volunteers and six patients studied prior to cranial irradiation; group 2 patients had cranial irradiation half a year before the SPECT study (n = 12, one from group 1); group 3 patients were irradiated 1 year before the study (n = 13, three from group 1 and two from group 2); and group 4 patients were irradiated at least 5 years before SPECT imaging (n = 9). Six patients were studied twice. Quantification of the 99mTc-HMPAO brain SPECT studies was done separately by three radiologists to obtain the hypothalamus/occipital (H/O) and hypothalamus/parasagittal (H/P) ratios. Endocrinologic studies were performed in all cases and the hypothalamus-thyrotroph-thyroid, hypothalamus-gonadotroph-testis (ovary), hypothalamus-lactotroph, hypothalamus-somatotroph, and hypothalamus-corticotroph-adrenal axes were evaluated separately. We determined that regional hypothalamic blood flow was reduced after cranial irradiation in patients with nasopharyngeal cancer. The H/O ratio of groups 3 and 4 did not differ from that of group 2 (one-half year after cranial irradiation). The H/O ratio was significantly reduced 6 months and 1 year after cranial irradiation; mean +/- SD = 0.5801 +/- 0.0829 (p less than .025), 0.5725 +/- 0.0791 (p less than .01) versus 0.6477 +/- 0.0458 before cranial irradiation, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1882739      PMCID: PMC8331607     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

Review 1.  Cytotoxic endocrinopathy: a legacy of insults.

Authors:  S M Shalet
Journal:  J R Soc Med       Date:  1997-04       Impact factor: 5.344

2.  The Effects of Negative Elements in Environment and Cancer on Female Reproductive System.

Authors:  Jiangxue Qu; Yuehan Li; Shujie Liao; Jie Yan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Stereotactic radiosurgery in pituitary adenomas: long-term single institution experience and role of the hypothalamic-pituitary axis.

Authors:  Kita Sallabanda; Sergey Usychkin; Fernando Puebla; José C Bustos; José A Gutiérrez-Diaz; Carmen Peraza; César Beltrán; Hugo Marsiglia; José Samblás
Journal:  J Radiosurg SBRT       Date:  2011

Review 4.  Hypopituitarism as a consequence of brain tumours and radiotherapy.

Authors:  Ken H Darzy; Stephen M Shalet
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 5.  Hypopituitarism following radiotherapy.

Authors:  Ken H Darzy; Stephen M Shalet
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

6.  A prospective study of hypothalamus pituitary function after cranial irradiation with or without radiosensitizing chemotherapy.

Authors:  T S Huang; S C Huang; M M Hsu
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

7.  Radiation exposure and cytotoxic endocrinopathy: It is time for action.

Authors:  Sanjay Kalra; Ambika Gopalakrishnan Unnikrishnan; Warren Lee
Journal:  Indian J Endocrinol Metab       Date:  2011-04

Review 8.  Growth Hormone Deficiency and Treatment in Childhood Cancer Survivors.

Authors:  Netanya I Pollock; Laurie E Cohen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-22       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.